SQZ Biotechnologies Co.

06/16/2022 | Press release | Distributed by Public on 06/16/2022 04:49

SQZ Biotechnologies Announces Generation of Dopaminergic Neurons from Human Pluripotent Stem Cells Through Single-Step Delivery of Six Cell-Fate Encoding RNAs